$CYDY
CytoDyn Inc.

2020 Q3 Form 10-K Financial Statement

#000119312520220598 Filed on August 14, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2020 2019 Q2
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $9.875M $19.97M $4.111M
YoY Change 224.2% 64.84% 87.74%
% of Gross Profit
Research & Development $15.19M $52.64M $9.195M
YoY Change 67.73% 23.89% 3.09%
% of Gross Profit
Depreciation & Amortization $505.0K $2.034M $497.5K
YoY Change -4.91% 63.39% 452.76%
% of Gross Profit
Operating Expenses $15.19M $74.65M $13.80M
YoY Change 20.23% 33.65% 23.29%
Operating Profit -$25.57M -$74.65M
YoY Change 102.4% 33.65%
Interest Expense -$5.254M $18.22M -$1.090M
YoY Change -226.39% 450.0% -376.78%
% of Operating Profit
Other Income/Expense, Net $94.00K $500.0K $0.00
YoY Change -100.0%
Pretax Income -$30.83M -$139.9M -$14.89M
YoY Change 90.74% 120.21% 54.82%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$30.83M -$139.9M -$14.89M
YoY Change 90.74% 130.46% 54.76%
Net Earnings / Revenue
Basic Earnings Per Share -$0.33
Diluted Earnings Per Share -$53.87K -$0.33 -$47.18K
COMMON SHARES
Basic Shares Outstanding 568.2M 421.1M 364.7M
Diluted Shares Outstanding 421.1M

Balance Sheet

Concept 2020 Q3 2020 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $18.20M $14.28M $2.613M
YoY Change 913.46% 446.59% 112.43%
Cash & Equivalents $18.20M $2.613M
Short-Term Investments
Other Short-Term Assets $3.202M $3.399M $2.666M
YoY Change 128.88% 27.49% 27.54%
Inventory $58.47M $19.15M
Prepaid Expenses $107.2K
Receivables
Other Receivables
Total Short-Term Assets $79.88M $36.83M $5.369M
YoY Change 2396.13% 585.87% 61.7%
LONG-TERM ASSETS
Property, Plant & Equipment $527.0K $231.2K $29.25K
YoY Change 1584.89% 690.53% 160.52%
Goodwill
YoY Change
Intangibles $15.48M
YoY Change 887.49%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $13.49M $13.69M $15.50M
YoY Change -11.2% -11.72% 882.32%
TOTAL ASSETS
Total Short-Term Assets $79.88M $36.83M $5.369M
Total Long-Term Assets $13.49M $13.69M $15.50M
Total Assets $93.36M $50.51M $20.87M
YoY Change 407.77% 141.99% 326.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $21.35M $29.48M $16.24M
YoY Change 77.21% 81.53% 2.51%
Accrued Expenses $36.94M $8.267M $160.0K
YoY Change 1418.41% 303.8% 175.94%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $3.586M
YoY Change -100.0% -100.0%
Long-Term Debt Due $18.12M $6.744M $4.200M
YoY Change 391.79% 60.58%
Total Short-Term Liabilities $76.42M $44.50M $26.93M
YoY Change 231.32% 65.27% 60.92%
LONG-TERM LIABILITIES
Long-Term Debt $13.86M $8.431M $454.6K
YoY Change 5908.41% 1754.62%
Other Long-Term Liabilities $314.0K $63.39K $2.407M
YoY Change -83.33% -97.37% 82.37%
Total Long-Term Liabilities $14.17M $8.494M $2.862M
YoY Change 570.09% 196.8% 116.19%
TOTAL LIABILITIES
Total Short-Term Liabilities $76.42M $44.50M $26.93M
Total Long-Term Liabilities $14.17M $8.494M $2.862M
Total Liabilities $90.59M $52.99M $29.79M
YoY Change 259.77% 77.9% 64.97%
SHAREHOLDERS EQUITY
Retained Earnings -$234.4M
YoY Change 35.39%
Common Stock $329.6K
YoY Change 51.95%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.768M -$2.480M -$8.913M
YoY Change
Total Liabilities & Shareholders Equity $93.36M $50.51M $20.87M
YoY Change 407.77% 141.99% 326.09%

Cashflow Statement

Concept 2020 Q3 2020 2019 Q2
OPERATING ACTIVITIES
Net Income -$30.83M -$139.9M -$14.89M
YoY Change 90.74% 130.46% 54.76%
Depreciation, Depletion And Amortization $505.0K $2.034M $497.5K
YoY Change -4.91% 63.39% 452.76%
Cash From Operating Activities -$40.95M -$68.80M -$9.512M
YoY Change 169.57% 36.34% 36.28%
INVESTING ACTIVITIES
Capital Expenditures $59.00K $41.00K -$42.10K
YoY Change 1144.99% 57.69%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$59.00K -$41.00K -$42.10K
YoY Change 1144.99% -8.89%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $2.185M
YoY Change
Cash From Financing Activities 44.93M 79.67M 11.43M
YoY Change 232.2% 51.04% 250.53%
NET CHANGE
Cash From Operating Activities -40.95M -68.80M -9.512M
Cash From Investing Activities -59.00K -41.00K -42.10K
Cash From Financing Activities 44.93M 79.67M 11.43M
Net Change In Cash 3.921M 10.83M 1.873M
YoY Change -334.69% 384.12% -150.35%
FREE CASH FLOW
Cash From Operating Activities -$40.95M -$68.80M -$9.512M
Capital Expenditures $59.00K $41.00K -$42.10K
Free Cash Flow -$41.01M -$68.85M -$9.470M
YoY Change 169.87% 36.35% 35.68%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
55488
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
29251
CY2020Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
13455872
CY2019Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
15475454
CY2020Q2 us-gaap Assets
Assets
50514135
CY2019Q2 us-gaap Assets
Assets
20874125
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14281830
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2612910
CY2020Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
498005
CY2019Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
107211
CY2020Q2 cydy Prepaid Service Fees Current
PrepaidServiceFeesCurrent
2890519
CY2019Q2 cydy Prepaid Service Fees Current
PrepaidServiceFeesCurrent
1704876
CY2020Q2 us-gaap Assets Current
AssetsCurrent
36827032
CY2019Q2 us-gaap Assets Current
AssetsCurrent
5369420
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
29479313
CY2019Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
16239434
CY2020Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6866003
CY2019Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1588552
CY2020Q2 cydy Accrued License Fees Current
AccruedLicenseFeesCurrent
12500
CY2019Q2 cydy Accrued License Fees Current
AccruedLicenseFeesCurrent
208600
CY2020Q2 us-gaap Interest Payable Current
InterestPayableCurrent
292178
CY2019Q2 us-gaap Interest Payable Current
InterestPayableCurrent
212777
CY2020Q2 us-gaap Liabilities
Liabilities
52994613
CY2019Q2 us-gaap Liabilities
Liabilities
29788185
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
50514135
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
20874125
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
0
CY2019Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
3586035
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
44500666
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
26926348
CY2020Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
8430556
CY2019Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
454568
CY2019Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
2407269
CY2020Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
8493947
CY2019Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2861837
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
519262
CY2019Q2 us-gaap Common Stock Value
CommonStockValue
329555
CY2020Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
351711333
CY2019Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
220119856
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-354710895
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-229363407
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-2480478
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
-8914060
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
286
CY2019Q2 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
159
CY2020 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1644625
CY2019 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1707068
CY2018 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1666017
CY2020 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
404340
CY2019 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
459085
CY2018 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
435609
CY2020 cydy Interest On Convertible Note Payable
InterestOnConvertibleNotePayable
7330843
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19972804
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12116743
CY2018 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7340605
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
52639981
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
42490144
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
38222580
CY2020 us-gaap Operating Expenses
OperatingExpenses
74647225
CY2019 cydy Interest On Convertible Note Payable
InterestOnConvertibleNotePayable
950617
CY2018 cydy Interest On Convertible Note Payable
InterestOnConvertibleNotePayable
251315
CY2020 us-gaap Interest Expense
InterestExpense
18219791
CY2019 us-gaap Interest Expense
InterestExpense
3312697
CY2018 us-gaap Interest Expense
InterestExpense
5924923
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2019Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
700000000
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
700000000
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
519261580
CY2019Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
329554763
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
518975572
CY2019Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
329395752
CY2019Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
159011
CY2020Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
286008
CY2019 us-gaap Operating Expenses
OperatingExpenses
55852054
CY2018 us-gaap Operating Expenses
OperatingExpenses
45919313
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-74647225
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-55852054
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-45919313
CY2020 us-gaap Investment Income Interest
InvestmentIncomeInterest
5318
CY2019 us-gaap Investment Income Interest
InvestmentIncomeInterest
4306
CY2018 us-gaap Investment Income Interest
InvestmentIncomeInterest
3620
CY2020 cydy Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
-9541704
CY2019 cydy Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
1666469
CY2018 cydy Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
1690935
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-124403402
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-59013579
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-50149681
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2826919
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-124403402
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-56186660
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-50149681
CY2020 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.30
CY2019 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.21
CY2018 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.29
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
421077605
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
272040933
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
174885422
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2034440
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1245167
CY2018 us-gaap Depreciation And Amortization
DepreciationAndAmortization
356128
CY2020 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
404340
CY2019 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
459085
CY2018 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
435609
CY2020 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1644625
CY2019 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1707068
CY2018 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1666017
CY2018 cydy Interest Related To Warrant Extensions
InterestRelatedToWarrantExtensions
826252
CY2020 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-9541704
CY2019 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
1666469
CY2018 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
1690935
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
6547803
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
3388095
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
1290777
CY2020 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1576437
CY2019 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
464201
CY2018 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-2256173
CY2020 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
19039667
CY2019 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1741370
CY2018 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
12365959
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-68803615
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-50466164
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-29897971
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
41095
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
25731
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-41095
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-45284
CY2020 cydy Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
12665799
CY2019 cydy Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
38268839
CY2018 cydy Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
25224212
CY2020 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
38421468
CY2018 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
3161131
CY2020 cydy Payment Of Offering Costs
PaymentOfOfferingCosts
2303268
CY2019 cydy Payment Of Offering Costs
PaymentOfOfferingCosts
4336426
CY2018 cydy Payment Of Offering Costs
PaymentOfOfferingCosts
3558789
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
79670031
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
52746512
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
29353833
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
10825321
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2235064
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-544138
CY2019 cydy Non Cash Finance Cost Associated With Placement Agents Warrants
NonCashFinanceCostAssociatedWithPlacementAgentsWarrants
260635
CY2018 cydy Non Cash Finance Cost Associated With Placement Agents Warrants
NonCashFinanceCostAssociatedWithPlacementAgentsWarrants
70383
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-124403402
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-56186660
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-50149681
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-354710895
CY2020Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
14000000
CY2019Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
3300000
CY2020 cydy Estimated Future Unvested Option Forfeitures
EstimatedFutureUnvestedOptionForfeitures
0.00
CY2020 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
286008
CY2020Q2 cydy Treasury Stock Par Value
TreasuryStockParValue
0.001
CY2020 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2019 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2018 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2020Q2 cydy Pre Launch Inventory
PreLaunchInventory
0
CY2019Q2 cydy Pre Launch Inventory
PreLaunchInventory
0
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3466509
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1231445
CY2017Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1775583
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14291830
CY2020Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
0
CY2019Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
2407269
CY2018 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
3855468
CY2019Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
2407269
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2020 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
3756406
CY2020Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
0
CY2019Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.45
CY2019Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.10
CY2020 cydy Accrued Interest To Convertible Note Payable
AccruedInterestToConvertibleNotePayable
153876
CY2020Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
833332
CY2020Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
15000000
CY2020Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.05
CY2020 cydy Convertible Promissory Note Maximum Redemption Amount
ConvertiblePromissoryNoteMaximumRedemptionAmount
950000
CY2020 cydy Gains Losses On Extinguishment Of Convertible Debt
GainsLossesOnExtinguishmentOfConvertibleDebt
0
CY2019 cydy Gains Losses On Extinguishment Of Convertible Debt
GainsLossesOnExtinguishmentOfConvertibleDebt
-1519603
CY2018 cydy Gains Losses On Extinguishment Of Convertible Debt
GainsLossesOnExtinguishmentOfConvertibleDebt
0
CY2018 cydy Interest Related To Convertible Debt
InterestRelatedToConvertibleDebt
2352045
CY2019 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1519603
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2826919
CY2020 us-gaap Interest Paid Net
InterestPaidNet
242817
CY2018 us-gaap Interest Paid Net
InterestPaidNet
9157
CY2019 cydy Accrued Interest To Convertible Note Payable
AccruedInterestToConvertibleNotePayable
225245
CY2019 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
3059159
CY2018 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
1574628
CY2019 cydy Non Cash Derivative Liability Associated With Convertible Note Payable
NonCashDerivativeLiabilityAssociatedWithConvertibleNotePayable
2750006
CY2018 cydy Non Cash Derivative Liability Associated With Convertible Note Payable
NonCashDerivativeLiabilityAssociatedWithConvertibleNotePayable
0
CY2018 us-gaap Stock Issued1
StockIssued1
242158
CY2019 cydy Stock Options And Warrants Outstanding Weighted Average Remaining Contractual Life Term
StockOptionsAndWarrantsOutstandingWeightedAverageRemainingContractualLifeTerm
P3Y7M27D
CY2019Q2 cydy Stock Options And Warrants Outstanding Aggregate Intrinsic Value
StockOptionsAndWarrantsOutstandingAggregateIntrinsicValue
896400
CY2020 cydy Stock Options And Warrants Grants In Period
StockOptionsAndWarrantsGrantsInPeriod
57720125
CY2020 cydy Stock Options And Warrants Grants In Period Weighted Average Exercise Price
StockOptionsAndWarrantsGrantsInPeriodWeightedAverageExercisePrice
0.47
CY2020 cydy Stock Options And Warrants Exercised In Period
StockOptionsAndWarrantsExercisedInPeriod
101852619
CY2020 cydy Stock Options And Warrants Exercised In Period Weighted Average Exercise Price
StockOptionsAndWarrantsExercisedInPeriodWeightedAverageExercisePrice
0.56
CY2020 cydy Stock Options And Warrants Forfeitures And Expirations In Period
StockOptionsAndWarrantsForfeituresAndExpirationsInPeriod
3098826
CY2020 cydy Stock Options And Warrants Forfeitures And Expirations In Period Weighted Average Exercise Price
StockOptionsAndWarrantsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0.74
CY2020Q2 cydy Stock Options And Warrants Outstanding Numbers
StockOptionsAndWarrantsOutstandingNumbers
131360529
CY2020Q2 cydy Stock Options And Warrants Outstanding Weighted Average Exercise Price
StockOptionsAndWarrantsOutstandingWeightedAverageExercisePrice
0.65
CY2020 cydy Stock Options And Warrants Outstanding Weighted Average Remaining Contractual Life Term
StockOptionsAndWarrantsOutstandingWeightedAverageRemainingContractualLifeTerm
P5Y9M14D
CY2020Q2 cydy Stock Options And Warrants Outstanding Exercisable Number
StockOptionsAndWarrantsOutstandingExercisableNumber
131357234
CY2020Q2 cydy Stock Options And Warrants Outstanding Exercisable Weighted Average Exercise Price
StockOptionsAndWarrantsOutstandingExercisableWeightedAverageExercisePrice
0.65
CY2020 cydy Stock Options And Warrants Outstanding Exercisable Weighted Average Remaining Contractual Term
StockOptionsAndWarrantsOutstandingExercisableWeightedAverageRemainingContractualTerm
P3Y9M14D
CY2019Q2 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
3500000
CY2020Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3500000
CY2019Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3500000
CY2020Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5189897
CY2019Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3170315
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
13455872
CY2019Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
15475454
CY2020Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
0
CY2019Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
0
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1700000
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1200000
CY2019Q2 cydy Accrued License Fees Current
AccruedLicenseFeesCurrent
600000
CY2019Q2 cydy Accrued License Fees Current
AccruedLicenseFeesCurrent
741000
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
-1103234
CY2018 cydy Issuance Of Common Stock In Private Stock Offering Value
IssuanceOfCommonStockInPrivateStockOfferingValue
17643451
CY2019 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
11558000
CY2019 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
0
CY2019 cydy Issuance Of Common Stock In Private Stock Offering Value
IssuanceOfCommonStockInPrivateStockOfferingValue
23487584
CY2019 cydy Adjustments To Additional Paid In Capital Offering Cost Related To Private Offering
AdjustmentsToAdditionalPaidInCapitalOfferingCostRelatedToPrivateOffering
-2697149
CY2019Q2 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
CY2019Q1 cydy Warrants At Fair Value Of Redemption Provision
WarrantsAtFairValueOfRedemptionProvision
1465008
CY2019Q1 cydy Relative Fair Value Of Equity Classified Warrants
RelativeFairValueOfEquityClassifiedWarrants
858353
CY2019Q1 cydy Warrants At Beneficial Conversion Feature
WarrantsAtBeneficialConversionFeature
2676639
CY2019Q1 cydy Proceeds From Issuance Of Convertible Promissory Notes
ProceedsFromIssuanceOfConvertiblePromissoryNotes
5000000
CY2020 cydy Percentage Of Outstanding Common Stock To Be Acquired
PercentageOfOutstandingCommonStockToBeAcquired
0.50
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1000000
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
150000
CY2020Q2 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
3500000
CY2018 cydy Adjustments To Additional Paid In Capital Offering Cost Related To Warrant Tender Offer
AdjustmentsToAdditionalPaidInCapitalOfferingCostRelatedToWarrantTenderOffer
-85381
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2000000
CY2020 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
4476000
CY2020Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
10000
CY2019Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
853599
CY2019Q2 cydy Miscellaneous Receivables Current
MiscellaneousReceivablesCurrent
90824
CY2020Q2 cydy Long Term Convertible Notes Payable Current
LongTermConvertibleNotesPayableCurrent
6744444
CY2019Q2 cydy Long Term Convertible Notes Payable Current
LongTermConvertibleNotesPayableCurrent
4200000
CY2020Q2 cydy Tender Offer Proceeds Held In Trust
TenderOfferProceedsHeldInTrust
10000
CY2019Q2 cydy Tender Offer Proceeds Held In Trust
TenderOfferProceedsHeldInTrust
853599
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1290777
CY2018 cydy Adjustment To Additional Paid In Capital Stock Issued For Board Compensation
AdjustmentToAdditionalPaidInCapitalStockIssuedForBoardCompensation
260190
CY2018 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
104546
CY2018 cydy Adjustments To Additional Paid In Capital Offering Cost Related To Equity Offering
AdjustmentsToAdditionalPaidInCapitalOfferingCostRelatedToEquityOffering
-1717597
CY2018 cydy Issuance Of Common Stock In Registered Direct Offering Value
IssuanceOfCommonStockInRegisteredDirectOfferingValue
13611419
CY2018 cydy Adjustments To Additional Paid In Capital Legal Fee With Registered Offerings
AdjustmentsToAdditionalPaidInCapitalLegalFeeWithRegisteredOfferings
-533436
CY2018 cydy Adjustments To Additional Paid In Capital Debt Discounts On Convertible Notes Payable
AdjustmentsToAdditionalPaidInCapitalDebtDiscountsOnConvertibleNotesPayable
1645011
CY2018 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
826252
CY2018 cydy Adjustment To Additional Paid In Capital Interest Expense Related To Warrant Tender Offer
AdjustmentToAdditionalPaidInCapitalInterestExpenseRelatedToWarrantTenderOffer
393685
CY2018 cydy Adjustment To Additional Paid In Capital Interest Expense Related To Conversion Of Note Payable
AdjustmentToAdditionalPaidInCapitalInterestExpenseRelatedToConversionOfNotePayable
2352045
CY2019 cydy Stock Issued During Period Value Redemption Of Note Payable
StockIssuedDuringPeriodValueRedemptionOfNotePayable
1455000
CY2019 cydy Stock Issue During Period Value Offering Costs Related To Registered Direct Offering
StockIssueDuringPeriodValueOfferingCostsRelatedToRegisteredDirectOffering
-1129516
CY2019 cydy Adjustments To Additional Paid In Capital Offering Costs Related To Debt Offering
AdjustmentsToAdditionalPaidInCapitalOfferingCostsRelatedToDebtOffering
260636
CY2019 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
3534992
CY2019 cydy Adjustments To Additional Paid In Capital Inducement Of Interest Expense On Warrant Exchange
AdjustmentsToAdditionalPaidInCapitalInducementOfInterestExpenseOnWarrantExchange
195927
CY2019 cydy Dividends On Series C Preferred Stock
DividendsOnSeriesCPreferredStock
-37351
CY2019 cydy Adjustments To Additional Paid In Capital Legal Fees In Connection With Equity Offering
AdjustmentsToAdditionalPaidInCapitalLegalFeesInConnectionWithEquityOffering
-242771
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3388095
CY2020 cydy Issuance Of Common Stock In Registered Direct Offering Value
IssuanceOfCommonStockInRegisteredDirectOfferingValue
12665799
CY2020 cydy Stock Issued During Period Value Privatewarrant Exercised
StockIssuedDuringPeriodValuePrivatewarrantExercised
6021093
CY2020 cydy Adjustments To Additional Paid In Capital Offering Cost Related To Exercise Of Warrants
AdjustmentsToAdditionalPaidInCapitalOfferingCostRelatedToExerciseOfWarrants
-197253
CY2020 cydy Adjustments To Additional Paid In Capital Legal Fees In Connection With Equity Offering
AdjustmentsToAdditionalPaidInCapitalLegalFeesInConnectionWithEquityOffering
-15877
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6547803
CY2018 cydy Interest Related To Warrant Tender Offer
InterestRelatedToWarrantTenderOffer
393685
CY2020 cydy Interest Expense Related To Accretion Of Convertible Notes Payable
InterestExpenseRelatedToAccretionOfConvertibleNotesPayable
6615146
CY2019 cydy Interest Expense Related To Accretion Of Convertible Notes Payable
InterestExpenseRelatedToAccretionOfConvertibleNotesPayable
512594
CY2020 cydy Increase Decrease In Miscellaneous Receivables
IncreaseDecreaseInMiscellaneousReceivables
90824
CY2019 cydy Increase Decrease In Miscellaneous Receivables
IncreaseDecreaseInMiscellaneousReceivables
-90824
CY2019 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
19553
CY2020 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
13409000
CY2019 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
3083700
CY2019 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
583200
CY2020 cydy Non Cash Derivative Liability Associated With Warrants
NonCashDerivativeLiabilityAssociatedWithWarrants
11948972
CY2020 cydy Stock Issued During Period Value Issued For Accrued Bonus Compensation
StockIssuedDuringPeriodValueIssuedForAccruedBonusCompensation
154552
CY2018 cydy Stock Issued During Period Value Issued For Accrued Bonus Compensation
StockIssuedDuringPeriodValueIssuedForAccruedBonusCompensation
214263
CY2019 us-gaap Consideration Received For Beneficial Interest Obtained For Transferring Financial Asset
ConsiderationReceivedForBeneficialInterestObtainedForTransferringFinancialAsset
3534992
CY2020 cydy Accrued Dividends On Series C Convertible Preferred Stock
AccruedDividendsOnSeriesCConvertiblePreferredStock
671971
CY2019 cydy Accrued Dividends On Series C Convertible Preferred Stock
AccruedDividendsOnSeriesCConvertiblePreferredStock
37351
CY2018Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1323732
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
131360528
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
178591849
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
132385269
CY2020Q2 cydy Finitelived Intangible Assets Website Development Costs Incurred
FinitelivedIntangibleAssetsWebsiteDevelopmentCostsIncurred
19553
CY2020 cydy Tax Cuts And Jobs Act Of2017 Blended Tax Rate
TaxCutsAndJobsActOf2017BlendedTaxRate
0.21
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.286
CY2019 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0
CY2020 cydy Effective Income Tax Rate Reconciliation Loss On Debt Conversion
EffectiveIncomeTaxRateReconciliationLossOnDebtConversion
0
CY2020 cydy Effective Income Tax Rate Reconciliation Derivative Gain Loss Percent
EffectiveIncomeTaxRateReconciliationDerivativeGainLossPercent
-0.016
CY2019 cydy Effective Income Tax Rate Reconciliation Derivative Gain Loss Percent
EffectiveIncomeTaxRateReconciliationDerivativeGainLossPercent
0.006
CY2018 cydy Effective Income Tax Rate Reconciliation Derivative Gain Loss Percent
EffectiveIncomeTaxRateReconciliationDerivativeGainLossPercent
0.010
CY2020 cydy Effective Income Tax Reconciliation Valuation Allowance From Asset Acquisition
EffectiveIncomeTaxReconciliationValuationAllowanceFromAssetAcquisition
0
CY2019 cydy Effective Income Tax Rate Reconciliation Nondeductible Expense Debt Issuance Costs Percent
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDebtIssuanceCostsPercent
0
CY2020 cydy Effective Income Tax Rate Reconciliation Nondeductible Expense Interest
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseInterest
-0.012
CY2019 cydy Effective Income Tax Rate Reconciliation Nondeductible Expense Interest
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseInterest
-0.003
CY2020 cydy Effective Income Tax Rate Reconciliation Inducement Charge
EffectiveIncomeTaxRateReconciliationInducementCharge
-0.013
CY2019 cydy Effective Income Tax Rate Reconciliation Inducement Charge
EffectiveIncomeTaxRateReconciliationInducementCharge
-0.001
CY2018 cydy Effective Income Tax Rate Reconciliation Inducement Charge
EffectiveIncomeTaxRateReconciliationInducementCharge
-0.020
CY2019 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
0
CY2019 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0
CY2018 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.001
CY2019 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0
CY2020 cydy Effective Income Tax Rate Reconciliation Tax Credit Carryforward
EffectiveIncomeTaxRateReconciliationTaxCreditCarryforward
-0.001
CY2019 cydy Effective Income Tax Rate Reconciliation Tax Credit Carryforward
EffectiveIncomeTaxRateReconciliationTaxCreditCarryforward
-0.038
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.131
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.169
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.003
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.048
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2020Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
55624018
CY2019Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
39996561
CY2020Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
2062692
CY2019Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
2062692
CY2020Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
4069035
CY2019Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
3628085
CY2020Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
349384
CY2019Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
251293
CY2020Q2 cydy Deferred Tax Assets Liabilities Net Property Plant And Equipment
DeferredTaxAssetsLiabilitiesNetPropertyPlantAndEquipment
-454
CY2019Q2 cydy Deferred Tax Assets Liabilities Net Property Plant And Equipment
DeferredTaxAssetsLiabilitiesNetPropertyPlantAndEquipment
-340
CY2020Q2 cydy Deferred Tax Assets Amortization
DeferredTaxAssetsAmortization
372877
CY2019Q2 cydy Deferred Tax Assets Amortization
DeferredTaxAssetsAmortization
329360
CY2019Q2 us-gaap Deferred Tax Liabilities Financing Arrangements
DeferredTaxLiabilitiesFinancingArrangements
308621
CY2019Q2 cydy Deferred Tax Assets Liability Difference In Acquired Assets
DeferredTaxAssetsLiabilityDifferenceInAcquiredAssets
2826919
CY2020Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
60105540
CY2019Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
43132111
CY2020Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
60105540
CY2019Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
43132111
CY2020Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
264900000
CY2018 cydy Stock Issue During Period Value Offering Costs Related To Registered Direct Offering
StockIssueDuringPeriodValueOfferingCostsRelatedToRegisteredDirectOffering
-857149
CY2020 us-gaap Other Income
OtherIncome
500000
CY2019Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
190500000
CY2018Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
139200000
CY2020Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
19146678
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
175743
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
114790
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
63391
CY2020 cydy Finance Charges
FinanceCharges
935630
CY2018 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.348
CY2019 cydy Effective Income Tax Rate Reconciliation Loss On Debt Conversion
EffectiveIncomeTaxRateReconciliationLossOnDebtConversion
-0.005
CY2019 cydy Effective Income Tax Reconciliation Valuation Allowance From Asset Acquisition
EffectiveIncomeTaxReconciliationValuationAllowanceFromAssetAcquisition
0.048
CY2020 cydy Effective Income Tax Rate Reconciliation Nondeductible Expense Debt Issuance Costs Percent
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDebtIssuanceCostsPercent
-0.001
CY2018 cydy Effective Income Tax Rate Reconciliation Nondeductible Expense Debt Issuance Costs Percent
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDebtIssuanceCostsPercent
-0.002
CY2018 cydy Effective Income Tax Rate Reconciliation Nondeductible Expense Interest
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseInterest
-0.001
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
-0.003
CY2018 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
-0.011
CY2018 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.044
CY2018 cydy Effective Income Tax Rate Reconciliation Tax Credit Carryforward
EffectiveIncomeTaxRateReconciliationTaxCreditCarryforward
0.041
CY2020Q2 cydy Deferred Tax Assets Liability Difference In Acquired Assets
DeferredTaxAssetsLiabilityDifferenceInAcquiredAssets
2483097
CY2020 cydy Interest Related To Warrant Extensions And Debt Conversion
InterestRelatedToWarrantExtensionsAndDebtConversion
7904353
CY2020 cydy Interest Related To Warrant Extensions And Debt Conversion
InterestRelatedToWarrantExtensionsAndDebtConversion
7904353
CY2019 cydy Interest Related To Warrant Extensions And Debt Conversion
InterestRelatedToWarrantExtensionsAndDebtConversion
195927
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
19146678
CY2020 cydy Proceeds From Stock Option Excercises
ProceedsFromStockOptionExcercises
5602541
CY2020 cydy Payments Of Principal On Maturity Of Short Term Convertible Notes
PaymentsOfPrincipalOnMaturityOfShortTermConvertibleNotes
460000
CY2020 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1725000
CY2020 cydy Exercise Of Option To Stock Buy Back Or Repurchase Shares Heldiin Escrow
ExerciseOfOptionToStockBuyBackOrRepurchaseSharesHeldiinEscrow
8342
CY2020 cydy Payment Of Bonuses And Payroll Taxes
PaymentOfBonusesAndPayrollTaxes
88568
CY2018 cydy Payment Of Bonuses And Payroll Taxes
PaymentOfBonusesAndPayrollTaxes
102064
CY2020 cydy Payments For Warrant Tender Offer Held In Trust
PaymentsForWarrantTenderOfferHeldInTrust
843599
CY2019 cydy Payments For Warrant Tender Offer Held In Trust
PaymentsForWarrantTenderOfferHeldInTrust
-853599
CY2020 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
15000000
CY2019 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
15460000
CY2018 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
4888500
CY2020 cydy Accrued Dividends On Series D Convertible Preferred Stock
AccruedDividendsOnSeriesDConvertiblePreferredStock
272115
CY2020 cydy Non Cash Consideration For Issue Of Common Stock For Service
NonCashConsiderationForIssueOfCommonStockForService
2620
CY2019 cydy Non Cash Consideration For Issue Of Common Stock For Service
NonCashConsiderationForIssueOfCommonStockForService
8342
CY2018 cydy Non Cash Consideration For Issue Of Common Stock For Service
NonCashConsiderationForIssueOfCommonStockForService
260190
CY2020 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
14938193
CY2019 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
1455000
CY2018 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
5788500
CY2019Q2 cydy Finitelived Intangible Assets Website Development Costs Incurred
FinitelivedIntangibleAssetsWebsiteDevelopmentCostsIncurred
19553
CY2020 dei Document Type
DocumentType
10-K
CY2020 dei Amendment Flag
AmendmentFlag
false
CY2020 dei Document Period End Date
DocumentPeriodEndDate
2020-05-31
CY2020 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2020 dei Entity Central Index Key
EntityCentralIndexKey
0001175680
CY2020 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--05-31
CY2020 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2020 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2020 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2019Q4 dei Entity Public Float
EntityPublicFloat
106487002
CY2019 cydy Stock Issued During Period Series C Convertible Stock Shares
StockIssuedDuringPeriodSeriesCConvertibleStockShares
3246
CY2019 cydy Adjustments To Additional Paid In Capital Offering Cost Related To Exercise Of Warrants
AdjustmentsToAdditionalPaidInCapitalOfferingCostRelatedToExerciseOfWarrants
-266986
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
-13157971
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
154552
CY2019 cydy Issuance Of Common Stock In Registered Direct Offering Value
IssuanceOfCommonStockInRegisteredDirectOfferingValue
11814739
CY2019 cydy Stock Issued During Period Series C Convertible Stock Value
StockIssuedDuringPeriodSeriesCConvertibleStockValue
3083700
CY2020 cydy Stock Issue During Period Value Offering Costs Related To Registered Direct Offering
StockIssueDuringPeriodValueOfferingCostsRelatedToRegisteredDirectOffering
-377859
CY2020 cydy Issuance Of Public Warrants Through Tender Offering Value
IssuanceOfPublicWarrantsThroughTenderOfferingValue
11900260
CY2019 cydy Adjustments To Additional Paid In Capital Debt Discount And Issuance Costs Related To Debt Offering
AdjustmentsToAdditionalPaidInCapitalDebtDiscountAndIssuanceCostsRelatedToDebtOffering
3059159
CY2019 cydy Stock Issued During Period Value Privatewarrant Exercised
StockIssuedDuringPeriodValuePrivatewarrantExercised
2966512
CY2020 cydy Stock Issued During Period Value Redemption Of Note Payable
StockIssuedDuringPeriodValueRedemptionOfNotePayable
10822188
CY2020 cydy Stock Issued During The Period Value Of Note Conversion And Extension Fees
StockIssuedDuringThePeriodValueOfNoteConversionAndExtensionFees
3899205
CY2020 cydy Adjustments To Additional Paid In Capital Relative Fai Rmarket Value Associated With Warrants Exercised
AdjustmentsToAdditionalPaidInCapitalRelativeFaiRmarketValueAssociatedWithWarrantsExercised
11948972
CY2020 cydy Adjustments To Additional Paid In Capital Offering Cost Related To Warrant Tender Offer
AdjustmentsToAdditionalPaidInCapitalOfferingCostRelatedToWarrantTenderOffer
-1058466
CY2020 cydy Adjustmentsto Additional Paid In Capital Inducement Of Debt Conversions
AdjustmentstoAdditionalPaidInCapitalInducementOfDebtConversions
2713014
CY2020 cydy Adjustments To Additional Paid In Capital Inducement Of Interest Expense On Warrant Exchange
AdjustmentsToAdditionalPaidInCapitalInducementOfInterestExpenseOnWarrantExchange
5191338
CY2020 cydy Stock Issued During Period Seriesc Preffered Stock Value
StockIssuedDuringPeriodSeriescPrefferedStockValue
4957000
CY2020 cydy Adjustments To Additiona Lpaid Incapital Offering Cost Related To Seriesc Preferred Offering
AdjustmentsToAdditionaLpaidIncapitalOfferingCostRelatedToSeriescPreferredOffering
-432368
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-8342
CY2020 cydy Dividends On Seriesc Preferred Stock
DividendsOnSeriescPreferredStock
-671971
CY2020 cydy Stock Issued During Period Series D Preferred Stock Value
StockIssuedDuringPeriodSeriesDPreferredStockValue
8452000
CY2020 cydy Adjustments To Additional Paid In Capital Offering Cost Related To Seriesd Preferred Offering
AdjustmentsToAdditionalPaidInCapitalOfferingCostRelatedToSeriesdPreferredOffering
-4645
CY2020 cydy Dividends On Seriesd Preferred Stock
DividendsOnSeriesdPreferredStock
-272115
CY2020 cydy Stock Issued During Period Value For Exercise Of Stock Options
StockIssuedDuringPeriodValueForExerciseOfStockOptions
5602541
CY2020Q2 us-gaap Prepaid Royalties
PrepaidRoyalties
100000
CY2019Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
160000
CY2020Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
10800000
CY2020Q1 us-gaap Sale Leaseback Transaction Monthly Rental Payments
SaleLeasebackTransactionMonthlyRentalPayments
9901
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Amortization
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization
-0.003
CY2020 cydy Effective Income Tax Rate Reconciliation Non Deductible Expense Irc162 Limitation
EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseIrc162Limitation
-0.024
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.032
CY2020Q2 cydy Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Vacation And Payroll Expenses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedVacationAndPayrollExpenses
111514
CY2020 cydy Payment Of Supply Commitment
PaymentOfSupplyCommitment
30000000
CY2020Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
0
CY2019Q4 us-gaap Interest Paid Net
InterestPaidNet
525000
CY2020 dei Entity Shell Company
EntityShellCompany
false
CY2020 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020 dei Entity Small Business
EntitySmallBusiness
true
CY2020 dei Entity Address State Or Province
EntityAddressStateOrProvince
WA
CY2020 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
981438
CY2019Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
37351
CY2019Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2019Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2019Q2 cydy Percentage Of Shares Issuable Upon Exercise Of Original Warrants
PercentageOfSharesIssuableUponExerciseOfOriginalWarrants
0.50
CY2018 cydy Warrants Granted Per Share
WarrantsGrantedPerShare
0.50
CY2018Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.50
CY2018 cydy Issuance Of Common Stock In Registered Direct Offering Per Share
IssuanceOfCommonStockInRegisteredDirectOfferingPerShare
0.50
CY2019 cydy Issuance Of Common Stock In Registered Direct Offering Per Share
IssuanceOfCommonStockInRegisteredDirectOfferingPerShare
0.50
CY2019Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.50
CY2020Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
19146678
CY2019Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
0
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1000000
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0
CY2018 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0
CY2020 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0
CY2018 cydy Effective Income Tax Rate Reconciliation Non Deductible Expense Irc162 Limitation
EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseIrc162Limitation
0
CY2018 cydy Effective Income Tax Rate Reconciliation Loss On Debt Conversion
EffectiveIncomeTaxRateReconciliationLossOnDebtConversion
0
CY2018 cydy Effective Income Tax Reconciliation Valuation Allowance From Asset Acquisition
EffectiveIncomeTaxReconciliationValuationAllowanceFromAssetAcquisition
0
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0
CY2020 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0
CY2019 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Amortization
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization
0
CY2018 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Amortization
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization
0
CY2019 cydy Effective Income Tax Rate Reconciliation Non Deductible Expense Irc162 Limitation
EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseIrc162Limitation
0
CY2019 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0
CY2018 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0
CY2020 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2020 dei Entity Registrant Name
EntityRegistrantName
CytoDyn Inc.
CY2020Q2 cydy Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Leasing Expenses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredLeasingExpenses
-429
CY2019Q2 cydy Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Leasing Expenses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredLeasingExpenses
0
CY2020Q2 us-gaap Deferred Tax Liabilities Financing Arrangements
DeferredTaxLiabilitiesFinancingArrangements
0
CY2020Q2 cydy Charitable Contribution Carry Forward
CharitableContributionCarryForward
0
CY2019Q2 cydy Charitable Contribution Carry Forward
CharitableContributionCarryForward
0
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
568242391
CY2020 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-22500000
CY2019 cydy Interest Related To Warrant Extensions And Debt Conversion
InterestRelatedToWarrantExtensionsAndDebtConversion
195927
CY2018 cydy Interest Related To Warrant Extensions And Debt Conversion
InterestRelatedToWarrantExtensionsAndDebtConversion
3571982
CY2020 cydy Legal Settlements
LegalSettlements
-22500000
CY2018 cydy Repayment Of Principal And Interest On Convertible Note
RepaymentOfPrincipalAndInterestOnConvertibleNote
259157
CY2020 cydy Effective Income Tax Rate Reconciliation Nondeductible Legal Settlement Expense
EffectiveIncomeTaxRateReconciliationNondeductibleLegalSettlementExpense
-0.038
CY2019 cydy Effective Income Tax Rate Reconciliation Nondeductible Legal Settlement Expense
EffectiveIncomeTaxRateReconciliationNondeductibleLegalSettlementExpense
0
CY2018 cydy Effective Income Tax Rate Reconciliation Nondeductible Legal Settlement Expense
EffectiveIncomeTaxRateReconciliationNondeductibleLegalSettlementExpense
0
CY2019 cydy Stock Options And Warrants Grants In Period
StockOptionsAndWarrantsGrantsInPeriod
64834121
CY2020 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Reclassifications </div></div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Certain prior year amounts shown in the accompanying consolidated financial statements have been reclassified to conform to the 2020 presentation. These reclassifications did not have any effect on total current assets, total assets, total current liabilities, total liabilities, total stockholders&#8217; (deficit) equity, net loss or earnings per shares. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2020 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Use of Estimates </div></div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of the consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2018Q2 cydy Stock Options And Warrants Outstanding Numbers
StockOptionsAndWarrantsOutstandingNumbers
132385269
CY2019 cydy Stock Options And Warrants Exercised In Period
StockOptionsAndWarrantsExercisedInPeriod
7541279
CY2018Q2 cydy Stock Options And Warrants Outstanding Weighted Average Exercise Price
StockOptionsAndWarrantsOutstandingWeightedAverageExercisePrice
0.80
CY2019 cydy Stock Options And Warrants Grants In Period Weighted Average Exercise Price
StockOptionsAndWarrantsGrantsInPeriodWeightedAverageExercisePrice
0.57
CY2019 cydy Stock Options And Warrants Exercised In Period Weighted Average Exercise Price
StockOptionsAndWarrantsExercisedInPeriodWeightedAverageExercisePrice
0.40
CY2019Q2 cydy Stock Options And Warrants Outstanding Numbers
StockOptionsAndWarrantsOutstandingNumbers
178591849
CY2019Q2 cydy Stock Options And Warrants Outstanding Weighted Average Exercise Price
StockOptionsAndWarrantsOutstandingWeightedAverageExercisePrice
0.71
CY2020Q2 cydy Stock Options And Warrants Outstanding Exercisable Aggregate Intrinsic Value
StockOptionsAndWarrantsOutstandingExercisableAggregateIntrinsicValue
295704000
CY2020Q2 cydy Stock Options And Warrants Outstanding Aggregate Intrinsic Value
StockOptionsAndWarrantsOutstandingAggregateIntrinsicValue
302961000
CY2018Q2 cydy Stock Options And Warrants Outstanding Aggregate Intrinsic Value
StockOptionsAndWarrantsOutstandingAggregateIntrinsicValue
3673
CY2018 cydy Stock Options And Warrants Outstanding Weighted Average Remaining Contractual Life Term
StockOptionsAndWarrantsOutstandingWeightedAverageRemainingContractualLifeTerm
P3Y9M10D
CY2020Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2019Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2019 cydy Stock Options And Warrants Forfeitures And Expirations In Period
StockOptionsAndWarrantsForfeituresAndExpirationsInPeriod
11086262
CY2019 cydy Stock Options And Warrants Forfeitures And Expirations In Period Weighted Average Exercise Price
StockOptionsAndWarrantsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0.81

Files In Submission

Name View Source Status
0001193125-20-220598-index-headers.html Edgar Link pending
0001193125-20-220598-index.html Edgar Link pending
0001193125-20-220598.txt Edgar Link pending
0001193125-20-220598-xbrl.zip Edgar Link pending
cydy-20200531.xml Edgar Link completed
cydy-20200531.xsd Edgar Link pending
cydy-20200531_cal.xml Edgar Link unprocessable
cydy-20200531_def.xml Edgar Link unprocessable
cydy-20200531_lab.xml Edgar Link unprocessable
cydy-20200531_pre.xml Edgar Link unprocessable
d923315d10k.htm Edgar Link pending
d923315dex1016.htm Edgar Link pending
d923315dex1042.htm Edgar Link pending
d923315dex1043.htm Edgar Link pending
d923315dex1058.htm Edgar Link pending
d923315dex1062.htm Edgar Link pending
d923315dex1063.htm Edgar Link pending
d923315dex1064.htm Edgar Link pending
d923315dex21.htm Edgar Link pending
d923315dex23.htm Edgar Link pending
d923315dex24.htm Edgar Link pending
d923315dex31.htm Edgar Link pending
d923315dex311.htm Edgar Link pending
d923315dex312.htm Edgar Link pending
d923315dex32.htm Edgar Link pending
d923315dex41.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g923315g14m69.jpg Edgar Link pending
g923315g29h65.jpg Edgar Link pending
g923315g49w36.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending